XLRN earnings call for the period ending September 30, 2020.
News & Analysis: Acceleron Pharma
XLRN earnings call for the period ending June 30, 2020.
XLRN earnings call for the period ending March 31, 2020.
Here's why Acceleron Pharma is a better buy than both Moderna and Inovio Pharmaceuticals.
In this David versus Goliath battle, which biotech offers investors a greater return?
Acceleron Pharma, Novavax, and TG Therapeutics are all on the cusp of hitting major milestones.
XLRN earnings call for the period ending December 31, 2019.
These companies could crush the broader markets this year.
Acceleron's shares skyrocketed last month after its experimental PAH drug hit the mark in a midstage trial.
The stock's price surged following a clinical trial success, but should investors now temper their enthusiasm?